[Retracted] Additional Benefits Conferred by Endoscopic Sclerotherapy to Liver Cirrhosis Patients Receiving Endoscopic Variceal Ligation

Table 1

Baseline characteristics of the three groups.

Characteristics	Ligation group (n)	Sclerotherapy group (n)	Combined group (n)	χ^2
Male/female	26/19	25/20	27/18	0.182	0.913
Age (year)	54.12 ± 8.67	53.69 ± 8.41	54.08 ± 8.36	0.035	0.965
Number of gastric varices (piece)	3.12 ± 0.64	3.14 ± 0.23	3.15 ± 0.37	0.053	0.949
Child–Pugh score	8.21 ± 1.24	8.20 ± 1.17	8.21 ± 1.24	0.003	0.997
Severity of gastric varices (case)				0.184	0.915
F2	24	23	25
F3	21	22	20
Cause of liver cirrhosis				0.193	0.956
Hepatitis B	26	25	26
Alcoholic cirrhosis	19	20	19
Duration of liver cirrhosis (year)	5.84 ± 1.64	5.82 ± 1.88	5.83 ± 1.76	0.001	0.999